PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
Enterprise IntelligenceQuarterly drug-development signals, programme moves, and catalysts.ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Leaderboards/Conditions by publications

Most-Researched Conditions by Publication

The therapeutic conditions with the most published psychedelic research papers tracked by Blossom.

  1. 1Depressive Disorders1,223 papers
  2. 2Anxiety Disorders769 papers
  3. 3Substance Use Disorders (SUD)570 papers
  4. 4Healthy Volunteers433 papers
  5. 5Neuroimaging & Brain Measures404 papers
  6. 6Major Depressive Disorder (MDD)397 papers
  7. 7PTSD347 papers
  8. 8Treatment-Resistant Depression (TRD)345 papers
  9. 9Safety & Risk Management328 papers
  10. 10Suicidality243 papers
  11. 11Schizophrenia205 papers
  12. 12Medicinal Chemistry & Drug Development193 papers
  13. 13Palliative & End-of-Life Distress183 papers
  14. 14Interpersonal Functioning & Social Connectedness178 papers
  15. 15Chronic Pain173 papers
  16. 16Set & Setting156 papers
  17. 17Personality & Trait Factors148 papers
  18. 18Adolescents132 papers
  19. 19Microdosing131 papers
  20. 20Bipolar Disorder125 papers

Rankings are computed from the papers and trials tracked in the Blossom database and refresh daily. Counts reflect what Blossom tracks, not necessarily the global total.